SlideShare a Scribd company logo
1 of 31
Download to read offline
Towards personalised cancer
medicine: Network analysis to
track the metabolic footprints of
cancer
- By VARSHIT DUSAD
Project Supervisors:
Dr. Diego Oyarzún
Dr. Hector Keun
Dr. Mauricio Barahona
Flux Balance Analysis
 Most common technique to
analyze metabolic networks.
 Provides steady state flux
distribution
 Needs constraints and objective
function for optimization!
 Biomass growth reaction
 ATP maintenance
Substrate Graph Reaction Graph Bipartite Graph
3 most common graph representations of a metabolic network
Imagine a network of 4 reactions comprising of metabolites A, B, C, D, E. F and G such that R1: A+B→C; R2: C+D→E; R3:
A→F; R4: A→G
Metabolite graph: Where metabolites are nodes and reactions are edges (left);
Reaction graph: Where reactions are nodes and metabolites are edges (right), and
Bipartite graph: Where both nodes and reactions are nodes and connected by edges.
Constraint
Based
Analysis
Graph
Theory
Mass
Flow
Graph
Metabolic
Networks
Mass flow graphs
Why Mass Flow Graphs?
Weighted and
Directed graphs.
1
Reduces over
contribution of
pool metabolites
2
Incorporates
context specific
information
3
CHALLENGES
GOALS
Many cancer models with varying quality
Assess and rank models best suited for MFG
Right modeling also needs right constraints
Cross-validate published results
How does MFG capture cancer metabolism?
Analyze MFGs in various genetic knockouts
Objectives
 Critical assessment of different cancer metabolic models to identifying best
set of models suited for applying MFG.
 To cross-validate the selected model’s behavior with published results.
 To characterize the metabolic properties of mass flow graphs for cell line
specific cancer metabolic models
 a. Constructing MFGs in diverse genetic and environmental conditions.
 b. Centrality analysis using PageRank and characterizing differences
between different MFGs.
 c. Evaluation of gene essentiality and synthetic lethality in the context
of MFGs.
Results
Models Publication Algorithm What’s different
mCADRE Wang et al, 2012 mCADRE 126 tissue specific
models including some
cancer models
CL Ghaffari et al, 2015 tINIT 11 models corresponding
to 11 different cancer
cell lines (CL)
INIT Agren et al, 2012 INIT 16 tissue specific cancer
models
Nam Nam et al, 2013 GIMME 8 tissue specific cancer
models + their
corresponding wild type
PRIME Yizhak et al, 2014 PRIME 60 models corresponding
to 60 NCI-60 cancer cell
lines
Critical Assessment of 5 group of Cancer GEMs
Critical Assessment of
Cancer GEMs
 Not absolute best or
worst but how valuable
are they as “off the
shelf”.
 Checked for total
number of reactions and
metabolites.
 Nam > CL > PRIME > INIT
> mCADRE
Critical Assessment
of Cancer GEMs
 4 group of models
compared*.
 Checked for total
number of subsystems.
 CL > Nam ≥ PRIME >
mCADRE
*INIT models lacked subsystem information
Critical Assessment
of Cancer GEMs
 All 5 group of models
compared.
 Checked for “Active
reactions” and “Active
metabolites”.
 mCADRE > PRIME ≥
Nam > INIT > CL
Critical Assessment
of Cancer GEMs
 3 group of models from
compared*.
 Checked for
Mass/Charge balance.
 Only artificial reactions
unbalanced as expected.
*Nam, CL, INIT lacked information for
checking mass and charge balance.
Additionally Recon1 has been added
for control.
Critical Assessment of
Cancer GEMs
 5 group of models from
different publications
compared.
 Checked for
biologically reasonable
simulation via bounds.
 PRIME > Nam >
mCADRE ≥ INIT ≥ CL
Qualitative model comparison
Biomass function Objective
function
Experimental
Confirmation
mCADRE NA NA NA
INIT NA NA NA
CL Exists
(Unconventional)
Exists
(Unconventional)
Yes - 1
Nam Exists Exists Literature
confirmation
PRIME Exists Exists Yes - 2
PRIME vs Nam
 Based on previous
results it appears that
Nam and PRIME models
are most useful
 Tested for known
metabolic properties:
Comparison with growth
rate
 PRIME
 Nam
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.12 0.13 0.14 0.15 0.16 0.17 0.18 0.19 0.2
Experimental(1/hr)
Prime models (mmol/gDw-hr)
Prime vs Experimental
R=0.69
0.084
0.085
0.086
0.087
0.088
0.089
0.09
0.091
0.092
0.093
0.022 0.024 0.026 0.028 0.03 0.032 0.034 0.036 0.038 0.04
Experimental(1/hr)
Nam models (mmol/gDw-hr)
Nam vs Experimental
R= - 0.90
PRIME vs Nam
 Based on previous
results it appears that
Nam and PRIME models
are most useful
 Tested for known
metabolic properties:
Simulating drug response
 PRIME
 Nam
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Biomassflux
Drugs
Drug simulation: PRIME models
786-0 A498 A549 ACHN BT-549
0
0.02
0.04
0.06
0.08
0.1
Biomassflux
Drugs
Drug simulation: Nam models
breast_cancer kidney_RCC__cancer
liver_HCC_cancer lung_SCC_cancer
lung_adenocarcinoma_cancer
Warburg Effect
 Cross-validating
published results:
Warburg effect.
 Below a certain oxygen
uptake minimum amount
of Lactate secreted will
be >0.
 Cell line: BT-549
 Oxygen threshold:
between -6 and -5.5
mmol●gDW-1●hr-1
Warburg Effect
 Cross-validating
published results:
Warburg effect.
 Below a certain oxygen
uptake minimum amount
of Lactate secreted will
be >0.
 All cell lines
 Oxygen threshold:
between variable for
each cell line.
Constraint Based analysis of cancer GEMs
 Based upon previous results, it was determined that PRIME models are best
candidates for reliable, as well as flexible flux simulations.
 However, flux simulation without proper constraints can still provide
biologically inaccurate results. Therefore, all the further simulations were
carried out in condition where the “Warburg effect” hypothesis was
confirmed.
 Standard: D-Glucose: -5, L-Glutamine: -1, D-Lactate release: 0.005
 noDLactate Constraint: D-Glucose: -5, L-Glutamine: -1
 Methotrexate: Standard + Dihydrofolate reductase knockout
 SDH Knockout: Standard + Succinate Dehydrogenase knockout.
 FH Knockout: Standard + Fumarate Hydratase knockout.
 Experimental measured fluxes as constraints (Jain et al, 2012)
 Oxygen level was variable for each cell line as determined in previous
results.
Pagerank Dependence on Flux
 Pagerank used to measure
importance of nodes!
 Absolute Pagerank will
depend upon flux to a very
high degree.
 Cell Line: A498
Pagerank Percentile
comparison.
 Cell Line: A498
 Pagerank percentile of reactions
changes in different conditions.
 Most reaction having shift in
pagerank have intermediate
pagerank percentile.
Pagerank Percentile
comparison
 Pagerank percentile of
reactions changes in
different conditions.
 Most reaction having
shift in pagerank have
intermediate pagerank
percentile.
Essentiality and Synthetic
Lethality
 Essential reactions: A is
essential if its knockout kills
cell.
 Synthetic lethal: A and B are
synthetically lethal if and
only if double knockout of A
and B kills the cell.
 Essentiality remained
constant with environment.
 Synthetic lethality changes
with changing environment.
 CellLine: A498
96 99 96
135
140
204
0
50
100
150
200
250
Default Artificial Real Data
Chart Title
Essential Synthetic Lethal
Centrality Lethality
Hypothesis (CLH)
 CLH states that in a
biological network,
nodes with high
centrality should be
essential.
 Cell Line: A498
 Pagerank percentile of
most essential
reactions is not high
 Similar results for
synthetic lethality
(Data not shown)
Conclusions
Genome scale models of
Cancer
1. Many cancer models exist,
with varying scope and utility.
2. Applying right constraints is
a must to achieve biologically
relevant results.
3. PRIME models were the best
fit to apply MFG.
Network Analysis of Mass
flow graphs
1. PageRank can provide more
information than flux alone.
2. PageRank captures changes
in network due to metabolic
perturbation.
3. PageRank and MFGs do not
support “Centrality Lethality
Hypothesis”.
• Identifying a centrality measure which
is similar to biological importance.
• Identifying the network property
which explains the basis of
essentiality.
• Integrating omics data sets to map
better constraints and even form new,
better models.
Future works

More Related Content

What's hot

Use of modelling and simulation to assess and manage individualized risk of d...
Use of modelling and simulation to assess and manage individualized risk of d...Use of modelling and simulation to assess and manage individualized risk of d...
Use of modelling and simulation to assess and manage individualized risk of d...Certara
 
Best practices and challenges for robust Quantitative proteomics of DMEs
Best practices and challenges for robust Quantitative proteomics of DMEsBest practices and challenges for robust Quantitative proteomics of DMEs
Best practices and challenges for robust Quantitative proteomics of DMEsDeepak Kumar Bhatt
 
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...Premier Publishers
 
Vitamin K poster_2013
Vitamin K poster_2013Vitamin K poster_2013
Vitamin K poster_2013David Garby
 
Cytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paper
Cytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paperCytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paper
Cytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paperAndrea Ujvari
 
dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...
dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...
dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...dkNET
 
AFP-L3% : IS IT AN EARLY MARKER FOR HCC ?
AFP-L3%  : IS IT AN EARLY MARKER FOR HCC ?AFP-L3%  : IS IT AN EARLY MARKER FOR HCC ?
AFP-L3% : IS IT AN EARLY MARKER FOR HCC ?Moustafa Rezk
 

What's hot (9)

Use of modelling and simulation to assess and manage individualized risk of d...
Use of modelling and simulation to assess and manage individualized risk of d...Use of modelling and simulation to assess and manage individualized risk of d...
Use of modelling and simulation to assess and manage individualized risk of d...
 
Best practices and challenges for robust Quantitative proteomics of DMEs
Best practices and challenges for robust Quantitative proteomics of DMEsBest practices and challenges for robust Quantitative proteomics of DMEs
Best practices and challenges for robust Quantitative proteomics of DMEs
 
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
Development and Validation of a Two-Site Immunoradiometric assay for Glypican...
 
Vitamin K poster_2013
Vitamin K poster_2013Vitamin K poster_2013
Vitamin K poster_2013
 
Aacr poster2007
Aacr poster2007Aacr poster2007
Aacr poster2007
 
Cytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paper
Cytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paperCytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paper
Cytoscan_Copy_Number_Confirmation_with_SYBR_Green_qPCR_white_paper
 
Gene_Identification_Report
Gene_Identification_ReportGene_Identification_Report
Gene_Identification_Report
 
dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...
dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...
dkNET Webinar: Population-Based Approaches to Investigate Endocrine Communica...
 
AFP-L3% : IS IT AN EARLY MARKER FOR HCC ?
AFP-L3%  : IS IT AN EARLY MARKER FOR HCC ?AFP-L3%  : IS IT AN EARLY MARKER FOR HCC ?
AFP-L3% : IS IT AN EARLY MARKER FOR HCC ?
 

Similar to Network analysis of cancer metabolism: A novel route to precision medicine

Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Elsa von Licy
 
Cell lines breast-project
Cell lines breast-projectCell lines breast-project
Cell lines breast-projectJaclynW
 
Ns Plus iFOBT WEO Final May 2011
Ns Plus iFOBT WEO Final May 2011Ns Plus iFOBT WEO Final May 2011
Ns Plus iFOBT WEO Final May 2011bpstat
 
Unc slides on computational toxicology
Unc slides on computational toxicologyUnc slides on computational toxicology
Unc slides on computational toxicologySean Ekins
 
Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...
Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...
Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...Rajarshi Guha
 
Finland Helsinki Drug Research slides 2011
Finland Helsinki Drug Research slides 2011Finland Helsinki Drug Research slides 2011
Finland Helsinki Drug Research slides 2011Sean Ekins
 
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdftony749601
 
BioIT Drug induced liver injury talk 2011
BioIT Drug induced liver injury talk 2011BioIT Drug induced liver injury talk 2011
BioIT Drug induced liver injury talk 2011Sean Ekins
 
Accelrys UGM slides 2011
Accelrys UGM slides 2011Accelrys UGM slides 2011
Accelrys UGM slides 2011Sean Ekins
 
Navigating through disease maps
Navigating through disease mapsNavigating through disease maps
Navigating through disease mapsJoaquin Dopazo
 
Talk at Yale University April 26th 2011: Applying Computational Models for To...
Talk at Yale University April 26th 2011: Applying Computational Modelsfor To...Talk at Yale University April 26th 2011: Applying Computational Modelsfor To...
Talk at Yale University April 26th 2011: Applying Computational Models for To...Sean Ekins
 
Systems Pharmacology as a tool for future therapy development: a feasibility ...
Systems Pharmacology as a tool for future therapy development: a feasibility ...Systems Pharmacology as a tool for future therapy development: a feasibility ...
Systems Pharmacology as a tool for future therapy development: a feasibility ...Guide to PHARMACOLOGY
 
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design IssuesExtending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design IssuesnQuery
 
Non-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample sizeNon-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample sizenQuery
 
Presentation july 31_2015
Presentation july 31_2015Presentation july 31_2015
Presentation july 31_2015gkoytiger
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTSheh Rawat
 
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...Simulations Plus, Inc.
 
Perspective on QSAR modeling of transport
Perspective on QSAR modeling of transportPerspective on QSAR modeling of transport
Perspective on QSAR modeling of transportSean Ekins
 
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...Thermo Fisher Scientific
 

Similar to Network analysis of cancer metabolism: A novel route to precision medicine (20)

Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013Drug metabolism and toxicity 2013
Drug metabolism and toxicity 2013
 
Cell lines breast-project
Cell lines breast-projectCell lines breast-project
Cell lines breast-project
 
Ns Plus iFOBT WEO Final May 2011
Ns Plus iFOBT WEO Final May 2011Ns Plus iFOBT WEO Final May 2011
Ns Plus iFOBT WEO Final May 2011
 
Unc slides on computational toxicology
Unc slides on computational toxicologyUnc slides on computational toxicology
Unc slides on computational toxicology
 
Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...
Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...
Exploring Compound Combinations in High Throughput Settings: Going Beyond 1D ...
 
Finland Helsinki Drug Research slides 2011
Finland Helsinki Drug Research slides 2011Finland Helsinki Drug Research slides 2011
Finland Helsinki Drug Research slides 2011
 
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
★★★2019 Quantitative Systems Pharmacology for Drug Discovery and Development.pdf
 
BioIT Drug induced liver injury talk 2011
BioIT Drug induced liver injury talk 2011BioIT Drug induced liver injury talk 2011
BioIT Drug induced liver injury talk 2011
 
Accelrys UGM slides 2011
Accelrys UGM slides 2011Accelrys UGM slides 2011
Accelrys UGM slides 2011
 
Navigating through disease maps
Navigating through disease mapsNavigating through disease maps
Navigating through disease maps
 
Talk at Yale University April 26th 2011: Applying Computational Models for To...
Talk at Yale University April 26th 2011: Applying Computational Modelsfor To...Talk at Yale University April 26th 2011: Applying Computational Modelsfor To...
Talk at Yale University April 26th 2011: Applying Computational Models for To...
 
ppt
pptppt
ppt
 
Systems Pharmacology as a tool for future therapy development: a feasibility ...
Systems Pharmacology as a tool for future therapy development: a feasibility ...Systems Pharmacology as a tool for future therapy development: a feasibility ...
Systems Pharmacology as a tool for future therapy development: a feasibility ...
 
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design IssuesExtending A Trial’s Design Case Studies Of Dealing With Study Design Issues
Extending A Trial’s Design Case Studies Of Dealing With Study Design Issues
 
Non-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample sizeNon-inferiority and Equivalence Study design considerations and sample size
Non-inferiority and Equivalence Study design considerations and sample size
 
Presentation july 31_2015
Presentation july 31_2015Presentation july 31_2015
Presentation july 31_2015
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCT
 
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
Discovery PBPK: How to estimate the expected accuracy of ISIVB and IVIVB for ...
 
Perspective on QSAR modeling of transport
Perspective on QSAR modeling of transportPerspective on QSAR modeling of transport
Perspective on QSAR modeling of transport
 
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
A Next-Generation Sequencing Assay to Estimate Tumor Mutation Load at > 5% Al...
 

Recently uploaded

Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksSérgio Sacani
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.Nitya salvi
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and ClassificationsAreesha Ahmad
 
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICESAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICEayushi9330
 
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticsPulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticssakshisoni2385
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsSérgio Sacani
 
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑Damini Dixit
 
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...Monika Rani
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)Areesha Ahmad
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .Poonam Aher Patil
 
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...dkNET
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY1301aanya
 
Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfSumit Kumar yadav
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bSérgio Sacani
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryAlex Henderson
 
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLKochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLkantirani197
 
COMPUTING ANTI-DERIVATIVES (Integration by SUBSTITUTION)
COMPUTING ANTI-DERIVATIVES(Integration by SUBSTITUTION)COMPUTING ANTI-DERIVATIVES(Integration by SUBSTITUTION)
COMPUTING ANTI-DERIVATIVES (Integration by SUBSTITUTION)AkefAfaneh2
 
SCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptx
SCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptxSCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptx
SCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptxRizalinePalanog2
 

Recently uploaded (20)

Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
Formation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disksFormation of low mass protostars and their circumstellar disks
Formation of low mass protostars and their circumstellar disks
 
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
❤Jammu Kashmir Call Girls 8617697112 Personal Whatsapp Number 💦✅.
 
Bacterial Identification and Classifications
Bacterial Identification and ClassificationsBacterial Identification and Classifications
Bacterial Identification and Classifications
 
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICESAMASTIPUR CALL GIRL 7857803690  LOW PRICE  ESCORT SERVICE
SAMASTIPUR CALL GIRL 7857803690 LOW PRICE ESCORT SERVICE
 
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceuticsPulmonary drug delivery system M.pharm -2nd sem P'ceutics
Pulmonary drug delivery system M.pharm -2nd sem P'ceutics
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
 
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
High Profile 🔝 8250077686 📞 Call Girls Service in GTB Nagar🍑
 
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
Vip profile Call Girls In Lonavala 9748763073 For Genuine Sex Service At Just...
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
dkNET Webinar "Texera: A Scalable Cloud Computing Platform for Sharing Data a...
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
 
Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdf
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRLKochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
Kochi ❤CALL GIRL 84099*07087 ❤CALL GIRLS IN Kochi ESCORT SERVICE❤CALL GIRL
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
COMPUTING ANTI-DERIVATIVES (Integration by SUBSTITUTION)
COMPUTING ANTI-DERIVATIVES(Integration by SUBSTITUTION)COMPUTING ANTI-DERIVATIVES(Integration by SUBSTITUTION)
COMPUTING ANTI-DERIVATIVES (Integration by SUBSTITUTION)
 
SCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptx
SCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptxSCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptx
SCIENCE-4-QUARTER4-WEEK-4-PPT-1 (1).pptx
 

Network analysis of cancer metabolism: A novel route to precision medicine

  • 1. Towards personalised cancer medicine: Network analysis to track the metabolic footprints of cancer - By VARSHIT DUSAD Project Supervisors: Dr. Diego Oyarzún Dr. Hector Keun Dr. Mauricio Barahona
  • 2.
  • 3. Flux Balance Analysis  Most common technique to analyze metabolic networks.  Provides steady state flux distribution  Needs constraints and objective function for optimization!  Biomass growth reaction  ATP maintenance
  • 4. Substrate Graph Reaction Graph Bipartite Graph 3 most common graph representations of a metabolic network Imagine a network of 4 reactions comprising of metabolites A, B, C, D, E. F and G such that R1: A+B→C; R2: C+D→E; R3: A→F; R4: A→G Metabolite graph: Where metabolites are nodes and reactions are edges (left); Reaction graph: Where reactions are nodes and metabolites are edges (right), and Bipartite graph: Where both nodes and reactions are nodes and connected by edges.
  • 7. Why Mass Flow Graphs? Weighted and Directed graphs. 1 Reduces over contribution of pool metabolites 2 Incorporates context specific information 3
  • 9. Many cancer models with varying quality Assess and rank models best suited for MFG Right modeling also needs right constraints Cross-validate published results How does MFG capture cancer metabolism? Analyze MFGs in various genetic knockouts
  • 10. Objectives  Critical assessment of different cancer metabolic models to identifying best set of models suited for applying MFG.  To cross-validate the selected model’s behavior with published results.  To characterize the metabolic properties of mass flow graphs for cell line specific cancer metabolic models  a. Constructing MFGs in diverse genetic and environmental conditions.  b. Centrality analysis using PageRank and characterizing differences between different MFGs.  c. Evaluation of gene essentiality and synthetic lethality in the context of MFGs.
  • 12. Models Publication Algorithm What’s different mCADRE Wang et al, 2012 mCADRE 126 tissue specific models including some cancer models CL Ghaffari et al, 2015 tINIT 11 models corresponding to 11 different cancer cell lines (CL) INIT Agren et al, 2012 INIT 16 tissue specific cancer models Nam Nam et al, 2013 GIMME 8 tissue specific cancer models + their corresponding wild type PRIME Yizhak et al, 2014 PRIME 60 models corresponding to 60 NCI-60 cancer cell lines Critical Assessment of 5 group of Cancer GEMs
  • 13. Critical Assessment of Cancer GEMs  Not absolute best or worst but how valuable are they as “off the shelf”.  Checked for total number of reactions and metabolites.  Nam > CL > PRIME > INIT > mCADRE
  • 14. Critical Assessment of Cancer GEMs  4 group of models compared*.  Checked for total number of subsystems.  CL > Nam ≥ PRIME > mCADRE *INIT models lacked subsystem information
  • 15. Critical Assessment of Cancer GEMs  All 5 group of models compared.  Checked for “Active reactions” and “Active metabolites”.  mCADRE > PRIME ≥ Nam > INIT > CL
  • 16. Critical Assessment of Cancer GEMs  3 group of models from compared*.  Checked for Mass/Charge balance.  Only artificial reactions unbalanced as expected. *Nam, CL, INIT lacked information for checking mass and charge balance. Additionally Recon1 has been added for control.
  • 17. Critical Assessment of Cancer GEMs  5 group of models from different publications compared.  Checked for biologically reasonable simulation via bounds.  PRIME > Nam > mCADRE ≥ INIT ≥ CL
  • 18. Qualitative model comparison Biomass function Objective function Experimental Confirmation mCADRE NA NA NA INIT NA NA NA CL Exists (Unconventional) Exists (Unconventional) Yes - 1 Nam Exists Exists Literature confirmation PRIME Exists Exists Yes - 2
  • 19.
  • 20. PRIME vs Nam  Based on previous results it appears that Nam and PRIME models are most useful  Tested for known metabolic properties: Comparison with growth rate  PRIME  Nam 0 0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.12 0.13 0.14 0.15 0.16 0.17 0.18 0.19 0.2 Experimental(1/hr) Prime models (mmol/gDw-hr) Prime vs Experimental R=0.69 0.084 0.085 0.086 0.087 0.088 0.089 0.09 0.091 0.092 0.093 0.022 0.024 0.026 0.028 0.03 0.032 0.034 0.036 0.038 0.04 Experimental(1/hr) Nam models (mmol/gDw-hr) Nam vs Experimental R= - 0.90
  • 21. PRIME vs Nam  Based on previous results it appears that Nam and PRIME models are most useful  Tested for known metabolic properties: Simulating drug response  PRIME  Nam 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 Biomassflux Drugs Drug simulation: PRIME models 786-0 A498 A549 ACHN BT-549 0 0.02 0.04 0.06 0.08 0.1 Biomassflux Drugs Drug simulation: Nam models breast_cancer kidney_RCC__cancer liver_HCC_cancer lung_SCC_cancer lung_adenocarcinoma_cancer
  • 22. Warburg Effect  Cross-validating published results: Warburg effect.  Below a certain oxygen uptake minimum amount of Lactate secreted will be >0.  Cell line: BT-549  Oxygen threshold: between -6 and -5.5 mmol●gDW-1●hr-1
  • 23. Warburg Effect  Cross-validating published results: Warburg effect.  Below a certain oxygen uptake minimum amount of Lactate secreted will be >0.  All cell lines  Oxygen threshold: between variable for each cell line.
  • 24. Constraint Based analysis of cancer GEMs  Based upon previous results, it was determined that PRIME models are best candidates for reliable, as well as flexible flux simulations.  However, flux simulation without proper constraints can still provide biologically inaccurate results. Therefore, all the further simulations were carried out in condition where the “Warburg effect” hypothesis was confirmed.  Standard: D-Glucose: -5, L-Glutamine: -1, D-Lactate release: 0.005  noDLactate Constraint: D-Glucose: -5, L-Glutamine: -1  Methotrexate: Standard + Dihydrofolate reductase knockout  SDH Knockout: Standard + Succinate Dehydrogenase knockout.  FH Knockout: Standard + Fumarate Hydratase knockout.  Experimental measured fluxes as constraints (Jain et al, 2012)  Oxygen level was variable for each cell line as determined in previous results.
  • 25. Pagerank Dependence on Flux  Pagerank used to measure importance of nodes!  Absolute Pagerank will depend upon flux to a very high degree.  Cell Line: A498
  • 26. Pagerank Percentile comparison.  Cell Line: A498  Pagerank percentile of reactions changes in different conditions.  Most reaction having shift in pagerank have intermediate pagerank percentile.
  • 27. Pagerank Percentile comparison  Pagerank percentile of reactions changes in different conditions.  Most reaction having shift in pagerank have intermediate pagerank percentile.
  • 28. Essentiality and Synthetic Lethality  Essential reactions: A is essential if its knockout kills cell.  Synthetic lethal: A and B are synthetically lethal if and only if double knockout of A and B kills the cell.  Essentiality remained constant with environment.  Synthetic lethality changes with changing environment.  CellLine: A498 96 99 96 135 140 204 0 50 100 150 200 250 Default Artificial Real Data Chart Title Essential Synthetic Lethal
  • 29. Centrality Lethality Hypothesis (CLH)  CLH states that in a biological network, nodes with high centrality should be essential.  Cell Line: A498  Pagerank percentile of most essential reactions is not high  Similar results for synthetic lethality (Data not shown)
  • 30. Conclusions Genome scale models of Cancer 1. Many cancer models exist, with varying scope and utility. 2. Applying right constraints is a must to achieve biologically relevant results. 3. PRIME models were the best fit to apply MFG. Network Analysis of Mass flow graphs 1. PageRank can provide more information than flux alone. 2. PageRank captures changes in network due to metabolic perturbation. 3. PageRank and MFGs do not support “Centrality Lethality Hypothesis”.
  • 31. • Identifying a centrality measure which is similar to biological importance. • Identifying the network property which explains the basis of essentiality. • Integrating omics data sets to map better constraints and even form new, better models. Future works